Compounds > dactinomycin

dactinomycin and bortezomib

dactinomycin has been researched along with bortezomib in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Al-Masri, H; Alkan, S; Meyer, P; Ni, H; Ozpuyan, F1
Kawai, A; Kondo, T; Nakatani, F; Noguchi, R; Ohtori, S; Ono, T; Sei, A; Sin, Y; Sugaya, J; Takeshita, F; Tsuchiya, R; Yoshida, A; Yoshimatsu, Y1
Iwata, S; Kawai, A; Kondo, T; Noguchi, R; Ono, T; Sin, Y; Sugaya, J; Tsuchiya, R; Yoshida, A; Yoshimatsu, Y1

Reviews

1 review(s) available for dactinomycin and bortezomib

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

4 other study(ies) available for dactinomycin and bortezomib

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Bortezomib induces apoptosis in T-cell prolymphocytic leukemia (T-PLL).
    Leukemia & lymphoma, 2007, Volume: 48, Issue:11

    Topics: Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Cell Survival; Cryopreservation; Dactinomycin; Drug Evaluation, Preclinical; Flow Cytometry; Humans; Leukemia, Prolymphocytic, T-Cell; Pyrazines; Time Factors; Tumor Cells, Cultured

2007
Establishment and characterization of NCC-ssRMS2-C1: a novel patient-derived cell line of spindle cell/sclerosing rhabdomyosarcoma.
    Human cell, 2021, Volume: 34, Issue:5

    Topics: Adult; Antineoplastic Agents; Bortezomib; Cell Line, Tumor; Dactinomycin; Depsipeptides; Gene Fusion; Head and Neck Neoplasms; Humans; Male; Muscle Proteins; Mutation; MyoD Protein; Nuclear Receptor Coactivator 2; Rhabdomyosarcoma; Sarcoma; Trabectedin; Transcription Factors

2021
Establishment and characterization of NCC-MFS4-C1: a novel patient-derived cell line of myxofibrosarcoma.
    Human cell, 2021, Volume: 34, Issue:6

    Topics: Aged; Antineoplastic Agents; Bortezomib; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Dactinomycin; Depsipeptides; DNA Copy Number Variations; Docetaxel; Drug Screening Assays, Antitumor; Female; Fibrosarcoma; Furans; Humans; Ketones; Neoplasm Invasiveness; Spheroids, Cellular

2021